KUALA LUMPUR, Feb 26 (Bernama) — Clinical Research Malaysia (CRM) inked two Memorandum of Understanding (MoU) with two prominent Singapore organizations in the field of clinical research. This will further pave the way for better Malaysia–Singapore collaborations in advancing drug development and research capabilities between both countries.
“We have embarked on completing the ecosystem for the Early Phase drug development work with CRM leading the way since 2016. It was a very proud moment today that these two prominent organizations have agreed to work with CRM and Institute of Medical Research (IMR) of the Ministry of Health on various projects in drug development including training of our doctors to be able to conduct early phase clinical trials,” said the Minister of Health and Chairman of CRM, YB Datuk Seri Dr. Dzulkefly Ahmad.
